Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Saturday, March 25, 2023.
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS)
Long-Term Downtrend (-90) - CRVS is in a strong downtrend that is likely to continue. While CRVS is showing intraday strength, it remains in the confines of a bearish trend. Traders should use caution and set stops.
Is it time to buy, sell, or avoid CRVS?
MarketClub looks at technical strength and momentum to determine if the timing is right for CRVS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for CRVS
The long-term trend has been DOWN since Mar 1st, 2023 at 0.70
The intermediate-term trend has been DOWN since Dec 13th, 2022 at 0.84
The short-term trend has been DOWN since Mar 20th, 2023 at 0.69
Smart Scan Analysis for CRVS
Based on our trend formula, CRVS is rated as a -90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 0.6847 | 0.7000 | 0.6500 | 0.6514 | -0.0287 |
| Prev. Close | Volume | Bid | Ask | Time |
| 0.6799 | 29565 | 2023-03-24 15:43:48 |
| Year High | 13.91 | Year High Date | 2018-06-15 |
| Year Low | 5.66 | Year Low Date | 2018-11-28 |
| 52wk High | 2.11 | 52wk High Date | 2022-04-05 |
| 52wk Low | 0.61 | 52wk Low Date | 2023-03-10 |
| Average Volume | 82,365 | Shares Outstanding | 46,554 |
| Market Cap | 121M | Assets | 80,348,000M |
| Liabilities | 15,667,000M | P/E Ratio | 21.5714 |
| Volatility | 63.98 |